Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Transplantation and Cellular Therapy|October 14, 2021
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 InfectionNishi Shah, Parastoo B Dahi, Doris M Ponce, et al.
Transplantation and Cellular Therapy|July 27, 2024
In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell TherapyChristopher E Dandoy, Joan Adams, Andrew Artz, et al.
Leukemia & Lymphoma|September 17, 2014
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplantParastoo B Dahi, Miguel A Perales, Sean M Devlin, et al.
Leukemia & Lymphoma|September 10, 2023
Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphomaParastoo B Dahi, Sheila Kenny, Jessica Flynn, et al.
Blood Advances|June 24, 2026
Late cytopenia after CD19 chimeric antigen receptor T cell in large B cell lymphoma: A Cell Therapy Consortium AnalysisKitsada Wudhikarn, Maria Bromberg, Jamie Brower, et al.
Transplantation and Cellular Therapy|May 11, 2022
Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell TransplantationParastoo B Dahi, Andrew Lin, Michael Scordo, et al.
Blood Advances|March 29, 2019
Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysisJuliet N Barker, Kirsten Boughan, Parastoo B Dahi, et al.
Transplantation and Cellular Therapy|October 8, 2023
Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell TherapyMaria-Stefania Infante, David Nemirovsky, Sean Devlin, et al.
Bone Marrow Transplantation|September 1, 2019
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignanciesRichard J Lin, Theresa A Elko, Sean M Devlin, et al.
Transplantation and Cellular Therapy|October 24, 2024
Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective CohortGiovanna Melica, Alejandro Luna de Abia, Gunjan L Shah, et al.
Pageof 9